BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sato Y, Hashimoto S, Mizuno KI, Takeuchi M, Terai S. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol 2016; 22(30): 6817-6828 [PMID: 27570419 DOI: 10.3748/wjg.v22.i30.6817] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 39] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Laird AM, Libutti SK. Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surg Oncol Clin N Am 2020;29:253-66. [PMID: 32151359 DOI: 10.1016/j.soc.2019.11.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Andreasi V, Partelli S, Muffatti F, Manzoni MF, Capurso G, Falconi M. Update on gastroenteropancreatic neuroendocrine tumors. Dig Liver Dis. 2021;53:171-182. [PMID: 32912771 DOI: 10.1016/j.dld.2020.08.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pedraza-Arévalo S, Gahete MD, Alors-Pérez E, Luque RM, Castaño JP. Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors. Rev Endocr Metab Disord 2018;19:179-92. [PMID: 30293213 DOI: 10.1007/s11154-018-9465-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
4 Krupka M, Bartusik-Aebisher D, Strzelczyk N, Latos M, Sieroń A, Cieślar G, Aebisher D, Czarnecka M, Kawczyk-Krupka A, Latos W. The role of autofluorescence, photodynamic diagnosis and Photodynamic therapy in malignant tumors of the duodenum. Photodiagnosis Photodyn Ther 2020;32:101981. [PMID: 32882405 DOI: 10.1016/j.pdpdt.2020.101981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Min BH, Hong M, Lee JH, Rhee PL, Sohn TS, Kim S, Kim KM, Kim JJ. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Br J Surg. 2018;105:1480-1486. [PMID: 29893418 DOI: 10.1002/bjs.10901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
6 Carvão J, Dinis-Ribeiro M, Pimentel-Nunes P, Libânio D. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE Port J Gastroenterol 2021;28:336-48. [PMID: 34604465 DOI: 10.1159/000512089] [Reference Citation Analysis]
7 Pak LM, Yang T, Wang J. Further Classification for Node-Positive Gastric Neuroendocrine Neoplasms. J Gastrointest Surg 2019;23:720-9. [DOI: 10.1007/s11605-018-3845-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Lu X, Yan S, Koral KA, Chen Z. Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors. Expert Rev Anticancer Ther 2021;21:917-26. [PMID: 34142932 DOI: 10.1080/14737140.2021.1944110] [Reference Citation Analysis]
9 Okamoto T, Yoshimoto T, Ohike N, Fujikawa A, Kanie T, Fukuda K. Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature. World J Gastroenterol 2021; 27(1): 129-142 [PMID: 33505155 DOI: 10.3748/wjg.v27.i1.129] [Reference Citation Analysis]
10 Imperiale A, Averous G, Helali M, Taieb D, Pessaux P, Goichot B, Addeo P, Bachellier P. Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms. Ann Nucl Med 2019;33:697-707. [DOI: 10.1007/s12149-019-01378-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Sitani K, Parghane RV, Talole S, Basu S. Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting. Br J Radiol 2021;94:20201041. [PMID: 33095671 DOI: 10.1259/bjr.20201041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Annibale B, Esposito G, Lahner E. A current clinical overview of atrophic gastritis. Expert Review of Gastroenterology & Hepatology 2020;14:93-102. [DOI: 10.1080/17474124.2020.1718491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
13 Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB. Management of Gastrointestinal Neuroendocrine Tumors. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419884058. [PMID: 31695546 DOI: 10.1177/1179551419884058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
14 Bouzakri N, Schulz S, Eickhoff A, Langer P. [A rare subtype of duodenal neuroendocrine tumors]. Chirurg 2021. [PMID: 34043039 DOI: 10.1007/s00104-021-01428-3] [Reference Citation Analysis]
15 Malczewska A, Procner A, Walter A, Kusnierz K, Zajecki W, Aslanian H, Kos-Kudla B. The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK. BMC Gastroenterol 2020;20:235. [PMID: 32703157 DOI: 10.1186/s12876-020-01348-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G. Current best practice in the management of neuroendocrine tumors. Ther Adv Endocrinol Metab. 2019;10:2042018818804698. [PMID: 30800264 DOI: 10.1177/2042018818804698] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
17 Yanagihara K, Kubo T, Iino Y, Mihara K, Morimoto C, Seyama T, Kuwata T, Ochiai A, Yokozaki H. Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line. Oncotarget 2019;10:2435-50. [PMID: 31069007 DOI: 10.18632/oncotarget.26764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Shiratori Y, Nakamura K, Suzuki K, Fukuda K. Endoscopic papillectomy for an ampullary neuroendocrine tumor. Clin J Gastroenterol 2020;13:1144-9. [PMID: 32816239 DOI: 10.1007/s12328-020-01212-6] [Reference Citation Analysis]
19 Eto K, Yoshida N, Iwagami S, Iwatsuki M, Baba H. Surgical treatment for gastrointestinal neuroendocrine tumors. Ann Gastroenterol Surg 2020;4:652-9. [PMID: 33319155 DOI: 10.1002/ags3.12396] [Reference Citation Analysis]
20 Li C, Chu Y, Lv L, Wang X, Yu M, Tan Y, Liu D. Safety and efficacy of endoscopic resection for the treatment of duodenal subepithelial lesions. J Gastrointest Oncol 2021;12:856-63. [PMID: 34012672 DOI: 10.21037/jgo-20-301] [Reference Citation Analysis]
21 Sundaresan S, Kang AJ, Merchant JL. Pathophysiology of Gastric NETs: Role of Gastrin and Menin. Curr Gastroenterol Rep 2017;19:32. [PMID: 28608155 DOI: 10.1007/s11894-017-0572-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Chen X, Li B, Wang S, Yang B, Zhu L, Ma S, Wu J, He Q, Zhao J, Zheng Z, Li S, Wang T, Liang L. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China. Scandinavian Journal of Gastroenterology 2019;54:384-9. [DOI: 10.1080/00365521.2019.1588367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Arora S, Rastogi S, Shamim SA, Barward AW, Passah BL. Coexisting Somatostatin Receptor Expressing Gastric Neuroendocrine Tumor Primary and Lymph Nodal Tuberculosis on 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. Indian J Nucl Med 2020;35:241-3. [PMID: 33082684 DOI: 10.4103/ijnm.IJNM_33_20] [Reference Citation Analysis]
24 Magris R, De Re V, Maiero S, Fornasarig M, Guarnieri G, Caggiari L, Mazzon C, Zanette G, Steffan A, Canzonieri V, Cannizzaro R. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. Clin Transl Gastroenterol 2020;11:e00238. [PMID: 33094954 DOI: 10.14309/ctg.0000000000000238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
25 Rohit M, Bhatt A, Cruise M, Wearsch PA, Goldblum JR, Sturgis CD. Endoscopic ultrasound FNA: An illustrated review of spindle cell neoplasms of the upper gastrointestinal tract including a novel case of gastric plexiform fibromyxoma. Diagn Cytopathol. 2018;46:730-738. [PMID: 30043412 DOI: 10.1002/dc.24040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
26 Yanagihara K, Kubo T, Mihara K, Kuwata T, Ochiai A, Seyama T, Yokozaki H. Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma. Oncotarget 2018;9:36503-14. [PMID: 30559933 DOI: 10.18632/oncotarget.26367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Norton JA, Kim T, Kim J, McCarter MD, Kelly KJ, Wong J, Sicklick JK. SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors. J Gastrointest Surg 2018;22:32-42. [PMID: 28808875 DOI: 10.1007/s11605-017-3533-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tirosh A, Papadakis GZ, Millo C, Sadowski SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, Green P, Keutgen XM, Patel D, Nilubol N, Kebebew E. Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements. Eur J Endocrinol 2017;176:575-82. [PMID: 28289088 DOI: 10.1530/EJE-16-1079] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
29 Gurzu S, Jung I, Borz C, Patrichi A, Yamada H, Sugimura H. Sporadic Multifocal Gastrinoma Mimicking a Duodenal GIST, in a Patient with MEN1 Gene Polymorphism D418D: an Unusual Case Report. J Gastrointest Cancer 2021;52:351-4. [PMID: 32705580 DOI: 10.1007/s12029-020-00461-5] [Reference Citation Analysis]
30 Kriger AG, Gorin DS, Panteleev VI, Kaldarov AR. Diagnosis and surgical treatment of duodenal tumors. Khir Z im N I Pirogova 2019. [DOI: 10.17116/hirurgia20190115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Hawa F, Sako Z, Nguyen T, Catanzaro AT, Zolotarevsky E, Bartley AN, Gunaratnam NT. The band and slough technique is effective for management of diminutive type 1 gastric and duodenal neuroendocrine tumors. Endosc Int Open 2020;8:E717-21. [PMID: 32490154 DOI: 10.1055/a-1119-6698] [Reference Citation Analysis]
32 Tashima T, Ryozawa S, Tanisaka Y, Fujita A, Miyaguchi K, Ogawa T, Mizuide M, Mashimo Y, Kawasaki T, Yasuda M. Endoscopic resection using an over-the-scope clip for duodenal neuroendocrine tumors. Endosc Int Open 2021;9:E659-66. [PMID: 33937505 DOI: 10.1055/a-1374-6141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bapatla A, Syed A, Mohammed AFS, Jones CV, Ismail R. Type I Gastric Neuroendocrine Tumor Presenting as Acute Upper Gastrointestinal Bleed. Cureus 2021;13:e15343. [PMID: 34094786 DOI: 10.7759/cureus.15343] [Reference Citation Analysis]
34 Baghdadi A, Ghadimi M, Mirpour S, Hazhirkarzar B, Motaghi M, Pawlik TM, Kamel IR. Imaging neuroendocrine tumors: Characterizing the spectrum of radiographic findings. Surg Oncol 2021;37:101529. [PMID: 33549952 DOI: 10.1016/j.suronc.2021.101529] [Reference Citation Analysis]
35 Naito S, Naito M, Yamamoto N, Kume T, Hosino S, Kinjyo Y, Naito Y, Naito H, Hasegawa S. Polypoid gallbladder neuroendocrine tumor diagnosed as benign polyp before surgery: A case report. Mol Clin Oncol 2020;12:225-9. [PMID: 32064098 DOI: 10.3892/mco.2019.1971] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Manfredi S, Walter T, Baudin E, Coriat R, Ruszniewski P, Lecomte T, Laurenty AP, Goichot B, Rohmer V, Roquin G, Cojocarasu OZ, Lombard-Bohas C, Lepage C, Morcet J, Cadiot G. Management of gastric neuro-endocrine tumours in a large French national cohort (GTE). Endocrine. 2017;57:504-511. [PMID: 28664309 DOI: 10.1007/s12020-017-1355-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Sakaray Y, Abuji K, Chatterjee D, Irrinki S. Giant retroperitoneal lymph node-an uncommon presentation of duodenal neuroendocrine tumour. BMJ Case Rep 2021;14:e243048. [PMID: 34290018 DOI: 10.1136/bcr-2021-243048] [Reference Citation Analysis]
38 Reghunath A, Kabilan K, Mittal MK. Exploring the neglected segment of the intestine: the duodenum and its pathologies. Pol J Radiol 2020;85:e230-44. [PMID: 32612721 DOI: 10.5114/pjr.2020.95477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Gluckman CR, Metz DC. Gastric Neuroendocrine Tumors (Carcinoids). Curr Gastroenterol Rep. 2019;21:13. [PMID: 30868284 DOI: 10.1007/s11894-019-0684-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]